Farmacología de la tuberculosis

In this educational video, we explore the pharmacology of tuberculosis (TB) in depth, focusing on the four first-line antituberculosis drugs that form the cornerstone of treatment: Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol. Ideal for medical, pharmacy, and nursing students, as well as healthcare professionals seeking to master the mechanisms of action, adverse effects, and clinical considerations of these essential medications. 00:00 Introduction and historical and epidemiological importance of tuberculosis. [02:08] Mycobacterial cell structure and its protective layers. [04:03] The process of infection in the lung, immune response, and granuloma formation. [06:58] Differences between latent tuberculosis and active disease (reactivation). [09:20] The problem of antimicrobial resistance and treatment duration. [11:24] Standard treatment regimen (2-month intensive phase and 4-month continuation phase). [14:16] Summary of drug-specific resistance mechanisms. [17:12] Rifampicin: Mechanism of action, indications, adverse effects, and dosage. [27:08] Isoniazid: Activation as a prodrug, neuropsychiatric adverse effects, and use of pyridoxine. [31:55] Pyrazinamide: Efficacy in acidic environments, membrane disruption, and risk of hyperuricemia/hepatotoxicity. [36:33] Ethambutol: Inhibition of arabinogalactan cell wall, bacteriostatic, and lower hepatotoxicity. [40:49] Final advice, sputum monitoring, management of hepatotoxicity, and drug-resistant tuberculosis.